Global Pharmacogenomics (PGx) Market Research Report 2025(Status and Outlook)

March 2025 | 192 pages | ID: G9BFCD8CFC3EEN
Bosson Research

Abstracts

Report Overview

Pharmacogenomics (PGx) is a field of study that combines pharmacology (the study of drugs) and genomics (the study of genes and their functions) to develop effective, safe medications tailored to an individual's genetic makeup. By analyzing how an individual's genetic characteristics influence their response to drugs, PGx aims to optimize drug therapy, minimize adverse drug reactions, and improve treatment outcomes. This personalized approach to medicine has the potential to revolutionize healthcare by providing targeted therapies based on a patient's unique genetic profile.

The market for Pharmacogenomics (PGx) is experiencing significant growth driven by several key factors. One of the primary market trends is the increasing adoption of personalized medicine across the healthcare industry. As healthcare providers and pharmaceutical companies recognize the value of tailoring treatment plans to individual patients, the demand for PGx testing and services is on the rise. Additionally, advancements in genomic technologies and bioinformatics have made genetic testing more accessible and affordable, further fueling market growth. Moreover, the growing prevalence of chronic diseases and the need for more effective and efficient treatment options are driving the expansion of the PGx market. At the same time, regulatory initiatives and government support for precision medicine initiatives are also contributing to the market's positive trajectory.

This report provides a deep insight into the global Pharmacogenomics (PGx) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pharmacogenomics (PGx) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pharmacogenomics (PGx) market in any manner.

Global Pharmacogenomics (PGx) Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Abbott Laboratories

Affymetrix

Inc.

Assurex Health

Inc

Astrazeneca

GeneDX

Illumina

Inc.

Laboratory Corporation of America Holdings

Myriad Genetics

Inc.

Pathway Genomics

Pfizer

Inc

Qiagen

Inc.

Rocheg

Teva Pharmaceutical Industries Ltd.

Thermo Fisher Scientific

Transgenomic

Inc.

Market Segmentation (by Type)

Polymerase Chain Reaction (PCR)

Microarray

Sequencing

Other

Market Segmentation (by Application)

Cardiovascular Diseases (CVD)

Central Nervous System (CNS)

Cancer/Oncology

Infectious Diseases

Other

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Pharmacogenomics (PGx) Market
• Overview of the regional outlook of the Pharmacogenomics (PGx) Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharmacogenomics (PGx) Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Pharmacogenomics (PGx)
1.2 Key Market Segments
1.2.1 Pharmacogenomics (PGx) Segment by Type
1.2.2 Pharmacogenomics (PGx) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Pharmacogenomics (PGx) Market Overview
2.1 Global Market Overview
2.1.1 Global Pharmacogenomics (PGx) Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Pharmacogenomics (PGx) Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Pharmacogenomics (PGx) Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Pharmacogenomics (PGx) Product Life Cycle
3.3 Global Pharmacogenomics (PGx) Sales by Manufacturers (2020-2025)
3.4 Global Pharmacogenomics (PGx) Revenue Market Share by Manufacturers (2020-2025)
3.5 Pharmacogenomics (PGx) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Pharmacogenomics (PGx) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Pharmacogenomics (PGx) Manufacturing Sites, Area Served, Product Type
3.8 Pharmacogenomics (PGx) Market Competitive Situation and Trends
3.8.1 Pharmacogenomics (PGx) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Pharmacogenomics (PGx) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Pharmacogenomics (PGx) Industry Chain Analysis
4.1 Pharmacogenomics (PGx) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Pharmacogenomics (PGx) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Pharmacogenomics (PGx) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Pharmacogenomics (PGx) Market
5.7 ESG Ratings of Leading Companies
6 Pharmacogenomics (PGx) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharmacogenomics (PGx) Sales Market Share by Type (2020-2025)
6.3 Global Pharmacogenomics (PGx) Market Size Market Share by Type (2020-2025)
6.4 Global Pharmacogenomics (PGx) Price by Type (2020-2025)
7 Pharmacogenomics (PGx) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharmacogenomics (PGx) Market Sales by Application (2020-2025)
7.3 Global Pharmacogenomics (PGx) Market Size (M USD) by Application (2020-2025)
7.4 Global Pharmacogenomics (PGx) Sales Growth Rate by Application (2020-2025)
8 Pharmacogenomics (PGx) Market Sales by Region
8.1 Global Pharmacogenomics (PGx) Sales by Region
8.1.1 Global Pharmacogenomics (PGx) Sales by Region
8.1.2 Global Pharmacogenomics (PGx) Sales Market Share by Region
8.2 Global Pharmacogenomics (PGx) Market Size by Region
8.2.1 Global Pharmacogenomics (PGx) Market Size by Region
8.2.2 Global Pharmacogenomics (PGx) Market Size Market Share by Region
8.3 North America
8.3.1 North America Pharmacogenomics (PGx) Sales by Country
8.3.2 North America Pharmacogenomics (PGx) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Pharmacogenomics (PGx) Sales by Country
8.4.2 Europe Pharmacogenomics (PGx) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Pharmacogenomics (PGx) Sales by Region
8.5.2 Asia Pacific Pharmacogenomics (PGx) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Pharmacogenomics (PGx) Sales by Country
8.6.2 South America Pharmacogenomics (PGx) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Pharmacogenomics (PGx) Sales by Region
8.7.2 Middle East and Africa Pharmacogenomics (PGx) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Pharmacogenomics (PGx) Market Production by Region
9.1 Global Production of Pharmacogenomics (PGx) by Region(2020-2025)
9.2 Global Pharmacogenomics (PGx) Revenue Market Share by Region (2020-2025)
9.3 Global Pharmacogenomics (PGx) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Pharmacogenomics (PGx) Production
9.4.1 North America Pharmacogenomics (PGx) Production Growth Rate (2020-2025)
9.4.2 North America Pharmacogenomics (PGx) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Pharmacogenomics (PGx) Production
9.5.1 Europe Pharmacogenomics (PGx) Production Growth Rate (2020-2025)
9.5.2 Europe Pharmacogenomics (PGx) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Pharmacogenomics (PGx) Production (2020-2025)
9.6.1 Japan Pharmacogenomics (PGx) Production Growth Rate (2020-2025)
9.6.2 Japan Pharmacogenomics (PGx) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Pharmacogenomics (PGx) Production (2020-2025)
9.7.1 China Pharmacogenomics (PGx) Production Growth Rate (2020-2025)
9.7.2 China Pharmacogenomics (PGx) Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Basic Information
10.1.2 Abbott Laboratories Pharmacogenomics (PGx) Product Overview
10.1.3 Abbott Laboratories Pharmacogenomics (PGx) Product Market Performance
10.1.4 Abbott Laboratories Business Overview
10.1.5 Abbott Laboratories SWOT Analysis
10.1.6 Abbott Laboratories Recent Developments
10.2 Affymetrix
10.2.1 Affymetrix Basic Information
10.2.2 Affymetrix Pharmacogenomics (PGx) Product Overview
10.2.3 Affymetrix Pharmacogenomics (PGx) Product Market Performance
10.2.4 Affymetrix Business Overview
10.2.5 Affymetrix SWOT Analysis
10.2.6 Affymetrix Recent Developments
10.3 Inc.
10.3.1 Inc. Basic Information
10.3.2 Inc. Pharmacogenomics (PGx) Product Overview
10.3.3 Inc. Pharmacogenomics (PGx) Product Market Performance
10.3.4 Inc. Business Overview
10.3.5 Inc. SWOT Analysis
10.3.6 Inc. Recent Developments
10.4 Assurex Health
10.4.1 Assurex Health Basic Information
10.4.2 Assurex Health Pharmacogenomics (PGx) Product Overview
10.4.3 Assurex Health Pharmacogenomics (PGx) Product Market Performance
10.4.4 Assurex Health Business Overview
10.4.5 Assurex Health Recent Developments
10.5 Inc
10.5.1 Inc Basic Information
10.5.2 Inc Pharmacogenomics (PGx) Product Overview
10.5.3 Inc Pharmacogenomics (PGx) Product Market Performance
10.5.4 Inc Business Overview
10.5.5 Inc Recent Developments
10.6 Astrazeneca
10.6.1 Astrazeneca Basic Information
10.6.2 Astrazeneca Pharmacogenomics (PGx) Product Overview
10.6.3 Astrazeneca Pharmacogenomics (PGx) Product Market Performance
10.6.4 Astrazeneca Business Overview
10.6.5 Astrazeneca Recent Developments
10.7 GeneDX
10.7.1 GeneDX Basic Information
10.7.2 GeneDX Pharmacogenomics (PGx) Product Overview
10.7.3 GeneDX Pharmacogenomics (PGx) Product Market Performance
10.7.4 GeneDX Business Overview
10.7.5 GeneDX Recent Developments
10.8 Illumina
10.8.1 Illumina Basic Information
10.8.2 Illumina Pharmacogenomics (PGx) Product Overview
10.8.3 Illumina Pharmacogenomics (PGx) Product Market Performance
10.8.4 Illumina Business Overview
10.8.5 Illumina Recent Developments
10.9 Inc.
10.9.1 Inc. Basic Information
10.9.2 Inc. Pharmacogenomics (PGx) Product Overview
10.9.3 Inc. Pharmacogenomics (PGx) Product Market Performance
10.9.4 Inc. Business Overview
10.9.5 Inc. Recent Developments
10.10 Laboratory Corporation of America Holdings
10.10.1 Laboratory Corporation of America Holdings Basic Information
10.10.2 Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Product Overview
10.10.3 Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Product Market Performance
10.10.4 Laboratory Corporation of America Holdings Business Overview
10.10.5 Laboratory Corporation of America Holdings Recent Developments
10.11 Myriad Genetics
10.11.1 Myriad Genetics Basic Information
10.11.2 Myriad Genetics Pharmacogenomics (PGx) Product Overview
10.11.3 Myriad Genetics Pharmacogenomics (PGx) Product Market Performance
10.11.4 Myriad Genetics Business Overview
10.11.5 Myriad Genetics Recent Developments
10.12 Inc.
10.12.1 Inc. Basic Information
10.12.2 Inc. Pharmacogenomics (PGx) Product Overview
10.12.3 Inc. Pharmacogenomics (PGx) Product Market Performance
10.12.4 Inc. Business Overview
10.12.5 Inc. Recent Developments
10.13 Pathway Genomics
10.13.1 Pathway Genomics Basic Information
10.13.2 Pathway Genomics Pharmacogenomics (PGx) Product Overview
10.13.3 Pathway Genomics Pharmacogenomics (PGx) Product Market Performance
10.13.4 Pathway Genomics Business Overview
10.13.5 Pathway Genomics Recent Developments
10.14 Pfizer
10.14.1 Pfizer Basic Information
10.14.2 Pfizer Pharmacogenomics (PGx) Product Overview
10.14.3 Pfizer Pharmacogenomics (PGx) Product Market Performance
10.14.4 Pfizer Business Overview
10.14.5 Pfizer Recent Developments
10.15 Inc
10.15.1 Inc Basic Information
10.15.2 Inc Pharmacogenomics (PGx) Product Overview
10.15.3 Inc Pharmacogenomics (PGx) Product Market Performance
10.15.4 Inc Business Overview
10.15.5 Inc Recent Developments
10.16 Qiagen
10.16.1 Qiagen Basic Information
10.16.2 Qiagen Pharmacogenomics (PGx) Product Overview
10.16.3 Qiagen Pharmacogenomics (PGx) Product Market Performance
10.16.4 Qiagen Business Overview
10.16.5 Qiagen Recent Developments
10.17 Inc.
10.17.1 Inc. Basic Information
10.17.2 Inc. Pharmacogenomics (PGx) Product Overview
10.17.3 Inc. Pharmacogenomics (PGx) Product Market Performance
10.17.4 Inc. Business Overview
10.17.5 Inc. Recent Developments
10.18 Rocheg
10.18.1 Rocheg Basic Information
10.18.2 Rocheg Pharmacogenomics (PGx) Product Overview
10.18.3 Rocheg Pharmacogenomics (PGx) Product Market Performance
10.18.4 Rocheg Business Overview
10.18.5 Rocheg Recent Developments
10.19 Teva Pharmaceutical Industries Ltd.
10.19.1 Teva Pharmaceutical Industries Ltd. Basic Information
10.19.2 Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Product Overview
10.19.3 Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Product Market Performance
10.19.4 Teva Pharmaceutical Industries Ltd. Business Overview
10.19.5 Teva Pharmaceutical Industries Ltd. Recent Developments
10.20 Thermo Fisher Scientific
10.20.1 Thermo Fisher Scientific Basic Information
10.20.2 Thermo Fisher Scientific Pharmacogenomics (PGx) Product Overview
10.20.3 Thermo Fisher Scientific Pharmacogenomics (PGx) Product Market Performance
10.20.4 Thermo Fisher Scientific Business Overview
10.20.5 Thermo Fisher Scientific Recent Developments
10.21 Transgenomic
10.21.1 Transgenomic Basic Information
10.21.2 Transgenomic Pharmacogenomics (PGx) Product Overview
10.21.3 Transgenomic Pharmacogenomics (PGx) Product Market Performance
10.21.4 Transgenomic Business Overview
10.21.5 Transgenomic Recent Developments
10.22 Inc.
10.22.1 Inc. Basic Information
10.22.2 Inc. Pharmacogenomics (PGx) Product Overview
10.22.3 Inc. Pharmacogenomics (PGx) Product Market Performance
10.22.4 Inc. Business Overview
10.22.5 Inc. Recent Developments
11 Pharmacogenomics (PGx) Market Forecast by Region
11.1 Global Pharmacogenomics (PGx) Market Size Forecast
11.2 Global Pharmacogenomics (PGx) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Pharmacogenomics (PGx) Market Size Forecast by Country
11.2.3 Asia Pacific Pharmacogenomics (PGx) Market Size Forecast by Region
11.2.4 South America Pharmacogenomics (PGx) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Pharmacogenomics (PGx) by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global Pharmacogenomics (PGx) Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Pharmacogenomics (PGx) by Type (2026-2033)
12.1.2 Global Pharmacogenomics (PGx) Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Pharmacogenomics (PGx) by Type (2026-2033)
12.2 Global Pharmacogenomics (PGx) Market Forecast by Application (2026-2033)
12.2.1 Global Pharmacogenomics (PGx) Sales (K Units) Forecast by Application
12.2.2 Global Pharmacogenomics (PGx) Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pharmacogenomics (PGx) Market Size Comparison by Region (M USD)
Table 5. Global Pharmacogenomics (PGx) Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Pharmacogenomics (PGx) Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Pharmacogenomics (PGx) Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Pharmacogenomics (PGx) Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenomics (PGx) as of 2024)
Table 10. Global Market Pharmacogenomics (PGx) Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Pharmacogenomics (PGx) Manufacturing Sites and Area Served
Table 12. Manufacturers Pharmacogenomics (PGx) Product Type
Table 13. Global Pharmacogenomics (PGx) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Pharmacogenomics (PGx) Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Pharmacogenomics (PGx) Sales by Type (K Units)
Table 25. Global Pharmacogenomics (PGx) Market Size by Type (M USD)
Table 26. Global Pharmacogenomics (PGx) Sales (K Units) by Type (2020-2025)
Table 27. Global Pharmacogenomics (PGx) Sales Market Share by Type (2020-2025)
Table 28. Global Pharmacogenomics (PGx) Market Size (M USD) by Type (2020-2025)
Table 29. Global Pharmacogenomics (PGx) Market Size Share by Type (2020-2025)
Table 30. Global Pharmacogenomics (PGx) Price (USD/Unit) by Type (2020-2025)
Table 31. Global Pharmacogenomics (PGx) Sales (K Units) by Application
Table 32. Global Pharmacogenomics (PGx) Market Size by Application
Table 33. Global Pharmacogenomics (PGx) Sales by Application (2020-2025) & (K Units)
Table 34. Global Pharmacogenomics (PGx) Sales Market Share by Application (2020-2025)
Table 35. Global Pharmacogenomics (PGx) Market Size by Application (2020-2025) & (M USD)
Table 36. Global Pharmacogenomics (PGx) Market Share by Application (2020-2025)
Table 37. Global Pharmacogenomics (PGx) Sales Growth Rate by Application (2020-2025)
Table 38. Global Pharmacogenomics (PGx) Sales by Region (2020-2025) & (K Units)
Table 39. Global Pharmacogenomics (PGx) Sales Market Share by Region (2020-2025)
Table 40. Global Pharmacogenomics (PGx) Market Size by Region (2020-2025) & (M USD)
Table 41. Global Pharmacogenomics (PGx) Market Size Market Share by Region (2020-2025)
Table 42. North America Pharmacogenomics (PGx) Sales by Country (2020-2025) & (K Units)
Table 43. North America Pharmacogenomics (PGx) Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Pharmacogenomics (PGx) Sales by Country (2020-2025) & (K Units)
Table 45. Europe Pharmacogenomics (PGx) Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Pharmacogenomics (PGx) Sales by Region (2020-2025) & (K Units)
Table 47. Asia Pacific Pharmacogenomics (PGx) Market Size by Region (2020-2025) & (M USD)
Table 48. South America Pharmacogenomics (PGx) Sales by Country (2020-2025) & (K Units)
Table 49. South America Pharmacogenomics (PGx) Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Pharmacogenomics (PGx) Sales by Region (2020-2025) & (K Units)
Table 51. Middle East and Africa Pharmacogenomics (PGx) Market Size by Region (2020-2025) & (M USD)
Table 52. Global Pharmacogenomics (PGx) Production (K Units) by Region(2020-2025)
Table 53. Global Pharmacogenomics (PGx) Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Pharmacogenomics (PGx) Revenue Market Share by Region (2020-2025)
Table 55. Global Pharmacogenomics (PGx) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. North America Pharmacogenomics (PGx) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. Europe Pharmacogenomics (PGx) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Japan Pharmacogenomics (PGx) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. China Pharmacogenomics (PGx) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Abbott Laboratories Basic Information
Table 61. Abbott Laboratories Pharmacogenomics (PGx) Product Overview
Table 62. Abbott Laboratories Pharmacogenomics (PGx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. Abbott Laboratories Business Overview
Table 64. Abbott Laboratories SWOT Analysis
Table 65. Abbott Laboratories Recent Developments
Table 66. Affymetrix Basic Information
Table 67. Affymetrix Pharmacogenomics (PGx) Product Overview
Table 68. Affymetrix Pharmacogenomics (PGx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 69. Affymetrix Business Overview
Table 70. Affymetrix SWOT Analysis
Table 71. Affymetrix Recent Developments
Table 72. Inc. Basic Information
Table 73. Inc. Pharmacogenomics (PGx) Product Overview
Table 74. Inc. Pharmacogenomics (PGx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Inc. Business Overview
Table 76. Inc. SWOT Analysis
Table 77. Inc. Recent Developments
Table 78. Assurex Health Basic Information
Table 79. Assurex Health Pharmacogenomics (PGx) Product Overview
Table 80. Assurex Health Pharmacogenomics (PGx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Assurex Health Business Overview
Table 82. Assurex Health Recent Developments
Table 83. Inc Basic Information
Table 84. Inc Pharmacogenomics (PGx) Product Overview
Table 85. Inc Pharmacogenomics (PGx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Inc Business Overview
Table 87. Inc Recent Developments
Table 88. Astrazeneca Basic Information
Table 89. Astrazeneca Pharmacogenomics (PGx) Product Overview
Table 90. Astrazeneca Pharmacogenomics (PGx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Astrazeneca Business Overview
Table 92. Astrazeneca Recent Developments
Table 93. GeneDX Basic Information
Table 94. GeneDX Pharmacogenomics (PGx) Product Overview
Table 95. GeneDX Pharmacogenomics (PGx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. GeneDX Business Overview
Table 97. GeneDX Recent Developments
Table 98. Illumina Basic Information
Table 99. Illumina Pharmacogenomics (PGx) Product Overview
Table 100. Illumina Pharmacogenomics (PGx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Illumina Business Overview
Table 102. Illumina Recent Developments
Table 103. Inc. Basic Information
Table 104. Inc. Pharmacogenomics (PGx) Product Overview
Table 105. Inc. Pharmacogenomics (PGx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Inc. Business Overview
Table 107. Inc. Recent Developments
Table 108. Laboratory Corporation of America Holdings Basic Information
Table 109. Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Product Overview
Table 110. Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Laboratory Corporation of America Holdings Business Overview
Table 112. Laboratory Corporation of America Holdings Recent Developments
Table 113. Myriad Genetics Basic Information
Table 114. Myriad Genetics Pharmacogenomics (PGx) Product Overview
Table 115. Myriad Genetics Pharmacogenomics (PGx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Myriad Genetics Business Overview
Table 117. Myriad Genetics Recent Developments
Table 118. Inc. Basic Information
Table 119. Inc. Pharmacogenomics (PGx) Product Overview
Table 120. Inc. Pharmacogenomics (PGx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Inc. Business Overview
Table 122. Inc. Recent Developments
Table 123. Pathway Genomics Basic Information
Table 124. Pathway Genomics Pharmacogenomics (PGx) Product Overview
Table 125. Pathway Genomics Pharmacogenomics (PGx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126. Pathway Genomics Business Overview
Table 127. Pathway Genomics Recent Developments
Table 128. Pfizer Basic Information
Table 129. Pfizer Pharmacogenomics (PGx) Product Overview
Table 130. Pfizer Pharmacogenomics (PGx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 131. Pfizer Business Overview
Table 132. Pfizer Recent Developments
Table 133. Inc Basic Information
Table 134. Inc Pharmacogenomics (PGx) Product Overview
Table 135. Inc Pharmacogenomics (PGx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 136. Inc Business Overview
Table 137. Inc Recent Developments
Table 138. Qiagen Basic Information
Table 139. Qiagen Pharmacogenomics (PGx) Product Overview
Table 140. Qiagen Pharmacogenomics (PGx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 141. Qiagen Business Overview
Table 142. Qiagen Recent Developments
Table 143. Inc. Basic Information
Table 144. Inc. Pharmacogenomics (PGx) Product Overview
Table 145. Inc. Pharmacogenomics (PGx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 146. Inc. Business Overview
Table 147. Inc. Recent Developments
Table 148. Rocheg Basic Information
Table 149. Rocheg Pharmacogenomics (PGx) Product Overview
Table 150. Rocheg Pharmacogenomics (PGx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 151. Rocheg Business Overview
Table 152. Rocheg Recent Developments
Table 153. Teva Pharmaceutical Industries Ltd. Basic Information
Table 154. Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Product Overview
Table 155. Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 156. Teva Pharmaceutical Industries Ltd. Business Overview
Table 157. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 158. Thermo Fisher Scientific Basic Information
Table 159. Thermo Fisher Scientific Pharmacogenomics (PGx) Product Overview
Table 160. Thermo Fisher Scientific Pharmacogenomics (PGx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 161. Thermo Fisher Scientific Business Overview
Table 162. Thermo Fisher Scientific Recent Developments
Table 163. Transgenomic Basic Information
Table 164. Transgenomic Pharmacogenomics (PGx) Product Overview
Table 165. Transgenomic Pharmacogenomics (PGx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 166. Transgenomic Business Overview
Table 167. Transgenomic Recent Developments
Table 168. Inc. Basic Information
Table 169. Inc. Pharmacogenomics (PGx) Product Overview
Table 170. Inc. Pharmacogenomics (PGx) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 171. Inc. Business Overview
Table 172. Inc. Recent Developments
Table 173. Global Pharmacogenomics (PGx) Sales Forecast by Region (2026-2033) & (K Units)
Table 174. Global Pharmacogenomics (PGx) Market Size Forecast by Region (2026-2033) & (M USD)
Table 175. North America Pharmacogenomics (PGx) Sales Forecast by Country (2026-2033) & (K Units)
Table 176. North America Pharmacogenomics (PGx) Market Size Forecast by Country (2026-2033) & (M USD)
Table 177. Europe Pharmacogenomics (PGx) Sales Forecast by Country (2026-2033) & (K Units)
Table 178. Europe Pharmacogenomics (PGx) Market Size Forecast by Country (2026-2033) & (M USD)
Table 179. Asia Pacific Pharmacogenomics (PGx) Sales Forecast by Region (2026-2033) & (K Units)
Table 180. Asia Pacific Pharmacogenomics (PGx) Market Size Forecast by Region (2026-2033) & (M USD)
Table 181. South America Pharmacogenomics (PGx) Sales Forecast by Country (2026-2033) & (K Units)
Table 182. South America Pharmacogenomics (PGx) Market Size Forecast by Country (2026-2033) & (M USD)
Table 183. Middle East and Africa Pharmacogenomics (PGx) Sales Forecast by Country (2026-2033) & (Units)
Table 184. Middle East and Africa Pharmacogenomics (PGx) Market Size Forecast by Country (2026-2033) & (M USD)
Table 185. Global Pharmacogenomics (PGx) Sales Forecast by Type (2026-2033) & (K Units)
Table 186. Global Pharmacogenomics (PGx) Market Size Forecast by Type (2026-2033) & (M USD)
Table 187. Global Pharmacogenomics (PGx) Price Forecast by Type (2026-2033) & (USD/Unit)
Table 188. Global Pharmacogenomics (PGx) Sales (K Units) Forecast by Application (2026-2033)
Table 189. Global Pharmacogenomics (PGx) Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of Pharmacogenomics (PGx)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pharmacogenomics (PGx) Market Size (M USD), 2024-2033
Figure 5. Global Pharmacogenomics (PGx) Market Size (M USD) (2020-2033)
Figure 6. Global Pharmacogenomics (PGx) Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pharmacogenomics (PGx) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Pharmacogenomics (PGx) Product Life Cycle
Figure 13. Pharmacogenomics (PGx) Sales Share by Manufacturers in 2024
Figure 14. Global Pharmacogenomics (PGx) Revenue Share by Manufacturers in 2024
Figure 15. Pharmacogenomics (PGx) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Pharmacogenomics (PGx) Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Pharmacogenomics (PGx) Revenue in 2024
Figure 18. Industry Chain Map of Pharmacogenomics (PGx)
Figure 19. Global Pharmacogenomics (PGx) Market PEST Analysis
Figure 20. Global Pharmacogenomics (PGx) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Pharmacogenomics (PGx) Market Share by Type
Figure 27. Sales Market Share of Pharmacogenomics (PGx) by Type (2020-2025)
Figure 28. Sales Market Share of Pharmacogenomics (PGx) by Type in 2024
Figure 29. Market Size Share of Pharmacogenomics (PGx) by Type (2020-2025)
Figure 30. Market Size Share of Pharmacogenomics (PGx) by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Pharmacogenomics (PGx) Market Share by Application
Figure 33. Global Pharmacogenomics (PGx) Sales Market Share by Application (2020-2025)
Figure 34. Global Pharmacogenomics (PGx) Sales Market Share by Application in 2024
Figure 35. Global Pharmacogenomics (PGx) Market Share by Application (2020-2025)
Figure 36. Global Pharmacogenomics (PGx) Market Share by Application in 2024
Figure 37. Global Pharmacogenomics (PGx) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Pharmacogenomics (PGx) Sales Market Share by Region (2020-2025)
Figure 39. Global Pharmacogenomics (PGx) Market Size Market Share by Region (2020-2025)
Figure 40. North America Pharmacogenomics (PGx) Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Pharmacogenomics (PGx) Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Pharmacogenomics (PGx) Sales Market Share by Country in 2024
Figure 43. North America Pharmacogenomics (PGx) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Pharmacogenomics (PGx) Market Size Market Share by Country in 2024
Figure 45. U.S. Pharmacogenomics (PGx) Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Pharmacogenomics (PGx) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Pharmacogenomics (PGx) Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Pharmacogenomics (PGx) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Pharmacogenomics (PGx) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Pharmacogenomics (PGx) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Pharmacogenomics (PGx) Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Pharmacogenomics (PGx) Sales Market Share by Country in 2024
Figure 53. Europe Pharmacogenomics (PGx) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Pharmacogenomics (PGx) Market Size Market Share by Country in 2024
Figure 55. Germany Pharmacogenomics (PGx) Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Pharmacogenomics (PGx) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Pharmacogenomics (PGx) Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Pharmacogenomics (PGx) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Pharmacogenomics (PGx) Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Pharmacogenomics (PGx) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Pharmacogenomics (PGx) Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Pharmacogenomics (PGx) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Pharmacogenomics (PGx) Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Pharmacogenomics (PGx) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Pharmacogenomics (PGx) Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Pharmacogenomics (PGx) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Pharmacogenomics (PGx) Market Size Market Share by Region in 2024
Figure 68. China Pharmacogenomics (PGx) Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Pharmacogenomics (PGx) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Pharmacogenomics (PGx) Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Pharmacogenomics (PGx) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Pharmacogenomics (PGx) Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Pharmacogenomics (PGx) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Pharmacogenomics (PGx) Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Pharmacogenomics (PGx) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Pharmacogenomics (PGx) Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Pharmacogenomics (PGx) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Pharmacogenomics (PGx) Sales and Growth Rate (K Units)
Figure 79. South America Pharmacogenomics (PGx) Sales Market Share by Country in 2024
Figure 80. South America Pharmacogenomics (PGx) Market Size and Growth Rate (M USD)
Figure 81. South America Pharmacogenomics (PGx) Market Size Market Share by Country in 2024
Figure 82. Brazil Pharmacogenomics (PGx) Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Pharmacogenomics (PGx) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Pharmacogenomics (PGx) Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Pharmacogenomics (PGx) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Pharmacogenomics (PGx) Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Pharmacogenomics (PGx) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Pharmacogenomics (PGx) Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Pharmacogenomics (PGx) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Pharmacogenomics (PGx) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Pharmacogenomics (PGx) Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Pharmacogenomics (PGx) Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Pharmacogenomics (PGx) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Pharmacogenomics (PGx) Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Pharmacogenomics (PGx) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Pharmacogenomics (PGx) Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Pharmacogenomics (PGx) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Pharmacogenomics (PGx) Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Pharmacogenomics (PGx) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Pharmacogenomics (PGx) Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Pharmacogenomics (PGx) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Pharmacogenomics (PGx) Production Market Share by Region (2020-2025)
Figure 103. North America Pharmacogenomics (PGx) Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Pharmacogenomics (PGx) Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Pharmacogenomics (PGx) Production (K Units) Growth Rate (2020-2025)
Figure 106. China Pharmacogenomics (PGx) Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Pharmacogenomics (PGx) Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Pharmacogenomics (PGx) Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Pharmacogenomics (PGx) Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Pharmacogenomics (PGx) Market Share Forecast by Type (2026-2033)
Figure 111. Global Pharmacogenomics (PGx) Sales Forecast by Application (2026-2033)
Figure 112. Global Pharmacogenomics (PGx) Market Share Forecast by Application (2026-2033)